» Articles » PMID: 22271511

Nonalcoholic Fatty Liver Disease is Associated with Coronary Artery Calcification

Overview
Journal Hepatology
Specialty Gastroenterology
Date 2012 Jan 25
PMID 22271511
Citations 137
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: Nonalcoholic fatty liver disease (NAFLD) is related to risk factors of coronary artery disease, such as dyslipidemia, diabetes, and metabolic syndrome, which are closely linked with visceral adiposity. The aim of this study was to investigate whether NAFLD was associated with coronary artery calcification (CAC), which is used as a surrogate marker for coronary atherosclerosis independent of computed tomography (CT)-measured visceral adiposity. Out of 5,648 subjects who visited one of our health screening centers between 2003 and 2008, we enrolled 4,023 subjects (mean age, 56.9 ± 9.4 years; 60.7% males) without known liver disease or a history of ischemic heart disease. CAC score was evaluated using the Agatston method. On univariate analysis, the presence of CAC (score >0) was significantly associated with age, sex, body mass index, aspartate aminotransferase, alanine aminotransferase, high-density lipoprotein cholesterol, triglycerides, and increased risk of diabetes, hypertension, smoking, and NAFLD. Increasing CAC scores (0, <10, 10-100, ≥ 100) were associated with higher prevalence of NAFLD (odds ratio [OR], 1.84; 95% confidence interval [CI], 1.61-2.10; P<0.001). Multivariable ordinal regression analysis was adjusted for traditional risk factors, and CT-measured visceral adipose tissue area in a subgroup of subjects showed that the increased CAC scores were significantly associated with the presence of NAFLD (OR, 1.28, 95% CI, 1.04-1.59; P = 0.023) independent of visceral adiposity.

Conclusion: Patients with NAFLD are at increased risk for coronary atherosclerosis independent of classical coronary risk factors, including visceral adiposity. These data suggest that NAFLD might be an independent risk factor for coronary artery disease.

Citing Articles

Visceral Obesity and Its Association with Severe Coronary Artery Calcification in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease.

Kang M, Song J, Kweon Y, Tak W, Park S, Lee Y Diagnostics (Basel). 2024; 14(20).

PMID: 39451628 PMC: 11506773. DOI: 10.3390/diagnostics14202305.


Non-Alcoholic Fatty Liver Disease and Coronary Artery Disease: A Bidirectional Association Based on Endothelial Dysfunction.

Ktenopoulos N, Sagris M, Gerogianni M, Pamporis K, Apostolos A, Balampanis K Int J Mol Sci. 2024; 25(19).

PMID: 39408924 PMC: 11477211. DOI: 10.3390/ijms251910595.


Influence of nonalcoholic fatty liver disease severity on carotid adventitial vasa vasorum.

Leon-Mengibar J, Sanchez E, Herrerias F, de la Fuente M, Santamaria M, Valdivielso J Front Endocrinol (Lausanne). 2024; 15:1366015.

PMID: 38774226 PMC: 11106423. DOI: 10.3389/fendo.2024.1366015.


Bridging Metabolic-Associated Steatotic Liver Disease and Cardiovascular Risk: A Potential Role for Ketogenesis.

Del Villar-Carrero R, Blanco A, Ruiz L, Garcia-Blanco M, Segovia R, de la Garza R Biomedicines. 2024; 12(3).

PMID: 38540305 PMC: 10968430. DOI: 10.3390/biomedicines12030692.


Global epidemiology of type 2 diabetes in patients with NAFLD or MAFLD: a systematic review and meta-analysis.

Cao L, An Y, Liu H, Jiang J, Liu W, Zhou Y BMC Med. 2024; 22(1):101.

PMID: 38448943 PMC: 10919055. DOI: 10.1186/s12916-024-03315-0.


References
1.
Dunn W, Xu R, Wingard D, Rogers C, Angulo P, Younossi Z . Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study. Am J Gastroenterol. 2008; 103(9):2263-71. PMC: 2574666. DOI: 10.1111/j.1572-0241.2008.02034.x. View

2.
Targher G, Bertolini L, Poli F, Rodella S, Scala L, Tessari R . Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. Diabetes. 2005; 54(12):3541-6. DOI: 10.2337/diabetes.54.12.3541. View

3.
Yim J, Kim D, Lim S, Park M, Choi S, Lee C . Sagittal abdominal diameter is a strong anthropometric measure of visceral adipose tissue in the Asian general population. Diabetes Care. 2010; 33(12):2665-70. PMC: 2992209. DOI: 10.2337/dc10-0606. View

4.
Kern P, Ranganathan S, Li C, Wood L, Ranganathan G . Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab. 2001; 280(5):E745-51. DOI: 10.1152/ajpendo.2001.280.5.E745. View

5.
Villanova N, Moscatiello S, Ramilli S, Bugianesi E, Magalotti D, Vanni E . Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. Hepatology. 2005; 42(2):473-80. DOI: 10.1002/hep.20781. View